Not of Standard Quality Drugs
|
Saturday 29 June 2013
Friday 28 June 2013
Tuesday 25 June 2013
Drug Patent Expirations for the week of June 23, 2013
Drug Patent Expirations for the week of June 23, 2013
| Tradename | Applicant | Generic Name | Patent No. | ||||||
|---|---|---|---|---|---|---|---|---|---|
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatchdatabase for complete details.
| |||||||||
Saturday 22 June 2013
Regulatory Affairs Useful Links
World Health Organisation (WHO)
http://www.who.int/
Heads of Medicines Agencies
http://www.hma.eu/index.html
European Medicines Agency (EMEA)
http://www.emea.eu.int/
Drug Information Association (DIA)
http://www.diahome.org
Medicines and Healthcare products Regulatory Agency (MHRA)
http://www.mhra.gov.uk
Food and Drug Administration (FDA)
http://www.fda.gov/
Eudralex
http://pharmacos.eudra.org/F2/eudralex/index.htm
Eudravigilance
http://eudravigilance.emea.europa.eu/highres.htm
Council for International Organizations of Medical Sciences
http://www.cioms.ch/
Annual Safety Reports: EU Clinical Trials Directive
http://www.wctn.org.uk/downloads/EU_Directive/Directive.pdf
Clinical Trials.Gov
http://www.clinicaltrials.gov
ISRCTN Register
http://www.isrctn.org
European Clinical Trials Database
https://eudract.emea.europa.eu/eudract/index.do
NICE
http://www.nice.org.uk/
British National Formulary
http://www.bnf.vhn.net/
Medicines Control Agency
http://www.open.gov.uk/mca/
ABPI
http://www.abpi.org.uk
MedDRA
http://www.meddramsso.com
Electronic Medicines Compendium
http://www.emc.vhn.net/
Embase
http://www.embase.com/
PUBMED
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
Medwatch
http://www.fda.gov/medwatch/
Medscape
http://www.medscape.com/
British Medical Journal
http://www.bmj.com/
Medicinenet.com
http://www.medicinenet.com/
Institute for Clinical Research (ICR)
http://www.icr-global.org
Pharmaceutical Research & Manufacturers of America (PhRMA)
http://www.phrma.org
European Generic Medicines Association (EGA)
http://www.egagenerics.com
British Generic Manufacturers Association (BGMA)
http://www.britishgenerics.co.uk
The Organisation for Professionals in Regulatory Affairs (TOPRA)
http://www.topra.org
Regulatory Affairs Professionals Society (RAPS)
http://www.raps.org
Pharmaceutical Information & Pharmacovigilance Association (PIPA)
http://www.pipaonline.org.uk
Bulgarian Drug Agency (BDA)
http://www.bda.bg
Danish Medicines Agency
http://www.dkma.dk
Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)
http://www.afssaps.sante.fr
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
http://www.bfarm.de
Icelandic Medicines Control Agency (IMCA)
http://www.imca.is
Irish Medicines Board (IMB)
http://www.imb.ie
Norwegian Medicines Agency
http://www.legemiddelverket.no
National Medicines and Health Products Authority (INFARMED)
http://www.infarmed.pt
Swissmedic, Schweizerisches Heilmittelinstitut
http://www.swissmedic.ch
Australia: Therapeutic Goods Administration
http://www.health.gov.au
Canada: Health Canada - Health Products and Food Branch
http://www.hc-sc.gc.ca
Japan: Ministry of Health, Labour and Welfare
http://www.mhlw.go.jp/english
New Zealand: Ministry of Health
http: www.moh.govt.nz
Tuesday 18 June 2013
Drug Patent Expirations for the week of June 16, 2013
Drug Patent Expirations for the week of June 16, 2013
| Tradename | Applicant | Generic Name | Patent No. | ||||||
|---|---|---|---|---|---|---|---|---|---|
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatchdatabase for complete details.
| |||||||||
Friday 14 June 2013
Wednesday 12 June 2013
Drug Patent Expirations for the week of June 9, 2013
Drug Patent Expirations for the week of June 9, 2013
| Tradename | Applicant | Generic Name | Patent No. | ||||||
|---|---|---|---|---|---|---|---|---|---|
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatchdatabase for complete details.
| |||||||||
Tuesday 11 June 2013
Ph.D Program @ G. Pulla Reddy College of Pharmacy (Courses Offered B-Pharm, M-Pharm and Ph.D)
The college is recognized as Research Centre by Osmania University to do Ph.D course in Pharmacy subjects.
There are five Doctorate Professors who are recognized as Ph.D supervisors by Osmania University. They are also recognized by JNTUH and many other universities to guide PhDs.
The college laboratories in the departments of
The college laboratories in the departments of
- Pharmaceutical Chemistry
- Pharmacognosy
- Pharmaceutics
- Pharmacology
- Ph. Analysis & Quality Assurance
Monday 10 June 2013
Sunday 9 June 2013
Friday 7 June 2013
120,000-year-old tumor discovered in Neanderthal Specimen
A tumor found in a Neanderthal specimen more than 120,000 years old may give scientists insight into the origins of cancer.
The rib tumor, which was an abnormal bone growth known as a fibrous dysplasia, is consistent with a kind of cancer that is found in modern-day people. It is one of the most common bone tumors in humans, the researchers noted.
"Evidence for cancer is extremely rare in the human fossil record. This case shows that Neanderthals, living in an unpolluted environment, were susceptible to the same kind of cancer as living humans," co-author David Frayer, a professor of biological anthropology at the University of Kansas, said in a press release.
The part was one of 876 fragments found in a rock shelter in Krapina, Croatia, in the late 1800s, and is thought to belong to one of a dozen individuals. Scientists have speculated that the bones were so fragmented either because the Neanderthals were cannibals or they were eaten by carnivorous animals, the Smithsonian reported.
The tumor was found by completing an X-ray and CT scan on a rib bone. The images showed a upward-protruding lesion on the rib that could not be an injury because there was no other traumas visible on the back of the rib.
Because the growth was found in an incomplete specimen, scientists will not be able to speculate about how the tumor affected the health of the Neanderthal.
The tumor was surprising because Neanderthals are estimated to have had half the lifespan of modern humans in developed countries, meaning this individual developed his issues earlier in life.
"Most cancers affect people when they get older, and most Neanderthals and earlier populations died before they got old. So this was really exciting to see," Frayer explained to National Geographic.
In addition, Neanderthals lived in completely different environmental factors so known carcinogens may not have been present.
"They didn't have pesticides, but they probably were sleeping in caves with burning fires," Frayer explained. "They were probably inhaling a lot of smoke from the caves. So the air was not completely free of pollutants -- but certainly, these Neanderthals weren't smoking cigarettes."
Before finding this tumor, the oldest evidence of cancer was between 1,000 to 4,000 years old.
"Some people think that cancer is only a modern disease, but there's evidence from fossils, bones and mummies that it's actually many thousands of years old," Kat Arney, science information manager at Cancer Research U.K., told the BBC. "So this discovery isn't entirely surprising, even though such finds are very rare, but it helps to shed light on the complex history of cancer in humans and our ancient relatives."
Source: cbsnews
Thursday 6 June 2013
Zydus New Chemical Entity Lipaglyn, has been approved by Drug Controller General of India.
Lipaglyn is the first Glitazar to be approved in the world and is the first NCE discovered and developed indigenously by an "Indian Pharma Company"
Wednesday 5 June 2013
Drug Patent Expirations for the week of June 2, 2013
Drug Patent Expirations for the week of June 2, 2013
| Tradename | Applicant | Generic Name | Patent No. | ||||||
|---|---|---|---|---|---|---|---|---|---|
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatchdatabase for complete details.
| |||||||||
Tuesday 4 June 2013
Subscribe to:
Posts (Atom)